Sumitomo Mitsui Trust Group
INDV icon

Sumitomo Mitsui Trust Group’s Indivior Pharmaceuticals INDV Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Sell
11,310
-4,110
-27% -$149K ﹤0.01% 986
2026
Q1 		$470K Sell
15,420
-7,060
-31% -$233K ﹤0.01% 945
2025
Q4 		$807K Sell
22,480
-7,700
-26% -$235K ﹤0.01% 885
2025
Q3 		$728K Buy
+30,180
New +$632K ﹤0.01% 888

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's INDV Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Indivior Pharmaceuticals (INDV) stake by 27% in Q2 2026, selling an estimated $149K and leaving 11,310 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #986.

Sumitomo Mitsui Trust Group first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $807K in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 11,310 shares of Indivior Pharmaceuticals worth $464K as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 4,110 Indivior Pharmaceuticals shares in Q2 2026, an estimated $149K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #986 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Sumitomo Mitsui Trust Group's Indivior Pharmaceuticals position peaked at $807K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.